空間ゲノミクスおよびトランスクリプトミクス市場- 世界の産業規模、シェア、動向、機会、予測、技法別、製品タイプ別、用途別、エンドユーザー別、地域別セグメント、競合、2020年～2030年

空間ゲノミクスおよびトランスクリプトミクスの世界市場は、2024年に9億8,425万米ドルと評価され、予測期間中に12.68％のCAGRで成長し、2030年には20億1,410万米ドルに達すると予測されています。

同市場の成長は、特に慢性疾患治療の領域で、疾患の早期発見と治療イノベーションに対する需要が増加していることが主因です。細胞ベースの研究への資金提供の急増と、がん診断のための新規細胞アッセイの開発が、市場をさらに押し上げています。さらに、NanoString Technologies社のGeoMx Digital Spatial Profiler（DSP）のような空間プロファイリング技術の進歩は、特にイルミナが提供するような次世代シーケンスプラットフォームと統合した場合に、調査能力を拡大しています。

市場促進要因

空間オミックスの技術進歩

主な市場課題

規制遵守と検証の複雑さ

主な市場動向

人工知能と機械学習の統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の空間ゲノミクスおよびトランスクリプトミクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技法別（空間トランスクリプトミクス、空間ゲノミクス解析）
  • 製品タイプ別（機器、消耗品、ソフトウェア）
  • 用途別（トランスレーショナル研究、.医薬品の発見と開発）
  • エンドユーザー別（製薬・バイオテクノロジー企業、受託研究機関、学術・研究機関）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024）
• 市場マップ
• 技術別
• 製品タイプ別
• 用途別
• エンドユーザー別
• 地域別

第6章 北米の空間ゲノミクスおよびトランスクリプトミクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の空間ゲノミクスおよびトランスクリプトミクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の空間ゲノミクスおよびトランスクリプトミクス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の空間ゲノミクスおよびトランスクリプトミクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの空間ゲノミクスおよびトランスクリプトミクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界の空間ゲノミクスおよびトランスクリプトミクス市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• 10X Genomics Inc.
• Akoya Bioscience Ltd.
• Biospyder Technologies Inc.
• BioTechne Corporation
• Dovetail Genomics LLC
• Fluidigm Corporation
• Genomic Vision SA
• Illumina Inc.
• Lunaphore Technologies SA
• Nanostring Technologies Inc

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Spatial Genomics and Transcriptomics Market was valued at USD 984.25 million in 2024 and is anticipated to reach USD 2014.10 million by 2030, growing at a CAGR of 12.68% during the forecast period. The market's growth is primarily driven by increasing demand for early disease detection and therapeutic innovation, particularly in the realm of chronic disease treatment. The surge in funding for cell-based research and the development of novel cell assays for cancer diagnostics is further propelling the market. Additionally, advancements in spatial profiling technologies-like the GeoMx Digital Spatial Profiler (DSP) by NanoString Technologies-have expanded research capabilities, especially when integrated with next-generation sequencing platforms such as those offered by Illumina.

Key Market Drivers

Technological Advancements in Spatial Omics

The rapid technological progress in spatial omics is significantly advancing the spatial genomics and transcriptomics market. High-resolution sequencing and imaging technologies have enabled researchers to map gene expression with spatial precision, enhancing the ability to study biological complexity within tissue samples. Platforms such as the 10x Genomics Visium have exemplified this by merging high-resolution imaging with spatial gene expression data. These innovations have broadened applications across oncology, neuroscience, and developmental biology by supporting the identification of biomarkers, understanding cellular heterogeneity, and enabling the development of targeted treatments. The convergence of spatial data with proteomics and metabolomics continues to enrich biological insight and therapeutic strategies.

Key Market Challenges

Regulatory Compliance and Validation Complexities

A key challenge for the spatial genomics and transcriptomics market lies in the complex and evolving landscape of regulatory compliance and validation. As these technologies integrate sequencing, imaging, and bioinformatics tools, they fall under multiple regulatory jurisdictions, creating ambiguity around standards and approval pathways. Agencies such as the FDA and EMA require rigorous validation for clinical applications, but the novel nature of spatial omics technologies makes it difficult to conform to existing regulatory frameworks. These tools often straddle research and clinical use, complicating standardization around performance metrics such as accuracy and reproducibility. This regulatory uncertainty can slow product approval timelines and hinder broader adoption in clinical settings.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning

Artificial Intelligence (AI) and Machine Learning (ML) are playing a transformative role in the spatial genomics and transcriptomics market. These technologies are increasingly being utilized to manage and analyze the complex, high-volume data generated by spatial omics platforms. AI and ML tools enable enhanced pattern recognition, spatial data inference, and integration with other omics datasets, improving resolution and interpretation. They assist in tasks such as image processing, cell segmentation, and predictive modeling, significantly boosting research accuracy and throughput. This integration is accelerating biomarker discovery, aiding drug development, and enhancing understanding of disease biology, while simultaneously optimizing workflow efficiency and result reproducibility.

Key Market Players

• 10X Genomics Inc.
• Akoya Bioscience Ltd.
• Biospyder Technologies Inc.
• BioTechne Corporation
• Dovetail Genomics LLC
• Fluidigm Corporation
• Genomic Vision SA
• Illumina Inc.
• Lunaphore Technologies SA
• Nanostring Technologies Inc.

Report Scope:

In this report, the Global Spatial Genomics and Transcriptomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spatial Genomics and Transcriptomics Market, By Technique:

• Spatial Transcriptomics
• Spatial Genomics Analysis

Spatial Genomics and Transcriptomics Market, By Product Type:

• Instruments
• Consumables
• Software

Spatial Genomics and Transcriptomics Market, By Application:

• Translational Research
• Drug Discovery & Development

Spatial Genomics and Transcriptomics Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes

Spatial Genomics and Transcriptomics Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spatial Genomics and Transcriptomics Market.

Available Customizations:

Global Spatial Genomics and Transcriptomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spatial Genomics and Transcriptomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 5.2.2. By Product Type (Instruments, Consumables, Software)
  • 5.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 5.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.6. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Technique
• 5.3.2 By Product Type
• 5.3.3 By Application
• 5.3.4 By End User
• 5.3.5 By Region

6. North America Spatial Genomics and Transcriptomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 6.2.2. By Product Type (Instruments, Consumables, Software)
  • 6.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 6.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Spatial Genomics and Transcriptomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Spatial Genomics and Transcriptomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Spatial Genomics and Transcriptomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Spatial Genomics and Transcriptomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 7.2.2. By Product Type (Instruments, Consumables, Software)
  • 7.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 7.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technique
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technique
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Spatial Genomics and Transcriptomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 8.2.2. By Product Type (Instruments, Consumables, Software)
  • 8.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 8.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technique
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technique
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Spatial Genomics and Transcriptomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 9.2.2. By Product Type (Instruments, Consumables, Software)
  • 9.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 9.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Spatial Genomics and Transcriptomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Spatial Genomics and Transcriptomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Spatial Genomics and Transcriptomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Spatial Genomics and Transcriptomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 10.2.2. By Product Type (Instruments, Consumables, Software)
  • 10.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 10.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Spatial Genomics and Transcriptomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technique
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Spatial Genomics and Transcriptomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technique
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Spatial Genomics and Transcriptomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technique
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Spatial Genomics and Transcriptomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. 10X Genomics Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Akoya Bioscience Ltd.
• 15.3. Biospyder Technologies Inc.
• 15.4. BioTechne Corporation
• 15.5. Dovetail Genomics LLC
• 15.6. Fluidigm Corporation
• 15.7. Genomic Vision SA
• 15.8. Illumina Inc.
• 15.9. Lunaphore Technologies SA
• 15.10. Nanostring Technologies Inc

16. Strategic Recommendations

17. About Us & Disclaimer